We are live on ! Find out more
LP

LMR Partners Portfolio holdings

AUM $45.4B
1-Year Est. Return 60.68%
This Fund
S&P 500
This Quarter Est. Return
+17.46%
1 Year Est. Return
+60.68%
3 Year Est. Return
+183.94%
5 Year Est. Return
+215.13%
10 Year Est. Return
+663.15%
AUM
$14B
AUM Growth
+$3.28B
Cap. Flow
+$324M
Cap. Flow %
2.32%
Top 10 Hldgs %
24.44%
Holding
1,743
New
418
Increased
280
Reduced
331
Closed
391

Top Buys

Rank Stock Value
1
MUB icon
iShares National Muni Bond ETF
MUB
+$176M
2
INFY icon
Infosys
INFY
+$102M
3
K
Kellanova
K
+$74.6M
4
AMZN icon
Amazon
AMZN
+$58.6M
5
BABA icon
Alibaba
BABA
+$52.5M

Sector Composition

Rank Sector Weight
1 Technology 10.38%
2 Financials 4.13%
3 Consumer Discretionary 2.33%
4 Communication Services 2.26%
5 Healthcare 2.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AIG icon
1301
American International
AIG
$41.9B
$86 ﹤0.01%
1
-73,724
-100% -$6.14M
USB icon
1302
US Bancorp
USB
$99.6B
$45 ﹤0.01%
+1
New +$42
EVGO icon
1303
EVgo
EVGO
$200M
$37 ﹤0.01%
10
BZAI
1304
Blaize Holdings
BZAI
$129M
$21 ﹤0.01%
+7
New +$17
PCG icon
1305
PG&E
PCG
$47.8B
$14 ﹤0.01%
1
-1,668
-100% -$27.1K
CLSK icon
1306
CleanSpark
CLSK
$3.73B
$11 ﹤0.01%
1
-29,999
-100% -$267K
A icon
1307
Agilent Technologies
A
$39.1B
-19,305
Closed -$2.26M
AAL icon
1308
PUT
American Airlines Group
AAL
$9.58B
-183,500
Closed -$1.94M
ABEO icon
1309
Abeona Therapeutics
ABEO
$345M
-27,120
Closed -$129K
ACRS icon
1310
Aclaris Therapeutics
ACRS
$730M
-48,360
Closed -$74K
ADM icon
1311
Archer Daniels Midland
ADM
$41.4B
-27,878
Closed -$1.34M
AES icon
1312
CALL
AES
AES
$10.6B
-136,500
Closed -$1.7M
AES icon
1313
AES
AES
$10.6B
-247,292
Closed -$3.07M
AES icon
1314
PUT
AES
AES
$10.6B
-36,500
Closed -$453K
ALNY icon
1315
Alnylam Pharmaceuticals
ALNY
$36.3B
-9,000
Closed -$2.43M
ALNY icon
1316
PUT
Alnylam Pharmaceuticals
ALNY
$36.3B
-5,800
Closed -$1.57M
AME icon
1317
Ametek
AME
$55.5B
-6,535
Closed -$1.12M
AMLX icon
1318
Amylyx Pharmaceuticals
AMLX
$2.05B
-43,228
Closed -$153K
AMP icon
1319
Ameriprise Financial
AMP
$46.8B
-1,545
Closed -$748K
ANSS
1320
PUT
DELISTED
Ansys
ANSS
-119,100
Closed -$37.7M
ANVS icon
1321
PUT
Annovis Bio
ANVS
$70.6M
-25,300
Closed -$38K
APA icon
1322
APA Corp
APA
$12.8B
-36,990
Closed -$778K
APP icon
1323
CALL
Applovin
APP
$132B
-21,300
Closed -$5.64M
APP icon
1324
Applovin
APP
$132B
-36,179
Closed -$9.59M
APP icon
1325
PUT
Applovin
APP
$132B
-22,100
Closed -$5.86M

Similar funds

LMR Partners's Q2 2025 Portfolio in Review

As of Q2 2025, LMR Partners held 1,743 positions worth $14B, up 31% from $10.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

LMR Partners's Q2 2025 filing shows 418 new, 280 increased, 331 reduced and 391 closed positions. Its largest new stake was Infosys: 5,733,005 shares worth $106M. The largest sale was Intra-Cellular Therapies Inc., an estimated $114M.

By sector, the portfolio is most concentrated in Technology at 10% of assets, down from 11% a quarter earlier, followed by Financials and Consumer Discretionary.

  • LMR Partners's largest Q2 2025 buy was Infosys: 5,733,005 shares worth $106M.
  • LMR Partners added most to iShares National Muni Bond ETF in Q2 2025, an estimated $176M increase.
  • LMR Partners's biggest Q2 2025 reduction was Roper Technologies, cutting an estimated $45.7M.
  • LMR Partners fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $114M.
  • LMR Partners's ten largest holdings make up 24% of its $14B portfolio in Q2 2025.
  • LMR Partners opened 418 new positions and closed 391 in Q2 2025.
  • LMR Partners's portfolio value rose 31% quarter-over-quarter to $14B.

Based on LMR Partners's 13F filing for Q2 2025, filed 14 Aug 2025.